Interní Med. 2002; 4(12): 11-14

Imunohistologické vyšetření kůže - praktické poznámky

MUDr. Olga Faustmannová
Dermatovenerologická klinika, FN Brno

Keywords: immunofluorescent technique, skin sample, immunohistological findings in selected diseases.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Faustmannová O. Imunohistologické vyšetření kůže - praktické poznámky. Interní Med. 2002;4(12):11-14.

Následující sdělení popisuje základní principy imunohistologického vyšetřování bioptického vzorku kůže, zásady uchování a zpracování. Popisuje vhodná místa odběru kůže u jednotlivých diagnóz, přináší popis imunohistologického obrazu u chorob, kde je toto vyšetření indikováno.

Immunohistological examination of skin - practical notes

The following paper describes basic principles of immunohistological examination of a bioptic sample of skin, standards of storage and processing. The suitable locations for skin biopsy are depicted according to a particular diagnosis. The descriptions of immuohistological pictures in different skin diseases, where skin biopsy is indicated, are outlined.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahmed AR, Kurgis BS, Rogers RS. Cicatricial pemphigoid. Journal of the American Academy of Dermatology 1991; 24: 987-1001. Go to original source... Go to PubMed...
    2. Boyd A, Neldner J. Lichen planus. Journal of the American Academy of Dermatology 1991; 25: 539-619. Go to original source... Go to PubMed...
    3. Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia -induced autoimmune disease. Archives of Dermatology 1993; 129: 883-886. Go to original source... Go to PubMed...
    4. Dahl MV. Ussefulness of direct immunofluorescence in patients with lupus erythematosus. Archives of Dermatology 1983; 119: 1010-1017. Go to original source... Go to PubMed...
    5. Jautová J, Jarčušková D, Szilašiová A, Martinásková K, Dubivská M. Prínos imunofluorescenčného vyšetrenia v diagnostike vaskulitid. Klin Imunol Alergológia 1995; 5: 10-12.
    6. Korman N. Bullous pemphigoid. Journal of the American Academy of Dermatology 1987; 16: 907-924. Go to original source... Go to PubMed...
    7. Kratochvil F. Využití a klinický význam imunofluorescenčních metod v dermatologii. Acta facultatis medicae Brno 1988.
    8. Maynard B, Peters MS. Histologic and immunofluorescence study of cutaneous porphyrie. Journal of Cutaneous Pathology 1992; 19: 40-47. Go to original source... Go to PubMed...
    9. Nousari HC, Anhalt GJ. Pemphigus vulgaris,paraneoplastic pemphigus and pemphigus foliaceus. In Kanitakis J, et al. Diagnostic Immunohistochemistry of the skin Chapman Hall Medical 1998: 74-83.
    10. Rowell NR, Goodfield MJD. Lupus erythematosus. In: Rook A, Wilkinson DS, Ebling FJG. Textbook of Dermatology. Champion RN 1998: 2438-2501.
    11. Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. International Journal of Dermatology 1991; 30: 307-312. Go to original source... Go to PubMed...
    12. Ullman S. Imunofluorescence and diseases of skin. Acta Dermatovenerologica 1989; (suppl. 1): 40-69.
    13. Vlašín Z. Immunohistology of the clinically normal skin in patients suffering from glomerolonephiritis. Scripta medica 1992; 65: 259-264.
    14. Wojnarowska F, Collier P, Allen J, Millard P. The localisation of the target antigens and antibodies in linear IgA disease is heterogenous and dependent on the methods used. British Journal of Dermatology 1995; 132: 750-757. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.